COVID-19 Vaccine intent in appalachian patients with multiple sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Vaccine intent in appalachian patients with multiple sclerosis
Authors
Keywords
Multiple sclerosis, COVID-19 vaccine, Vaccine intent, Appalachian, Vaccine hesitancy
Journal
Multiple Sclerosis and Related Disorders
Volume 57, Issue -, Pages 103450
Publisher
Elsevier BV
Online
2021-12-06
DOI
10.1016/j.msard.2021.103450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey
- (2021) Jeanette B. Ruiz et al. VACCINE
- Factors Associated with COVID-19 Vaccine Hesitancy among People with Epilepsy in Lithuania
- (2021) Kristijonas Puteikis et al. International Journal of Environmental Research and Public Health
- Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021
- (2021) Bhavini Patel Murthy et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
- (2021) Yingzhu Li et al. ACS Central Science
- Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021
- (2021) Michael Daly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
- (2021) Hannah Kelly et al. JOURNAL OF NEUROIMMUNOLOGY
- Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
- (2021) Saúl Reyes et al. JOURNAL OF NEUROIMMUNOLOGY
- COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021
- (2021) Dawn M. Ehde et al. Multiple Sclerosis and Related Disorders
- COVID-19 Vaccination Coverage and Intent Among Adults Aged 18–39 Years — United States, March–May 2021
- (2021) Brittney N. Baack et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults
- (2020) Kimberly A. Fisher et al. ANNALS OF INTERNAL MEDICINE
- Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
- (2020) Paul L. Reiter et al. VACCINE
- Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination
- (2020) Sarah Kreps et al. JAMA Network Open
- Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
- (2020) Georges Jalkh et al. Vaccines
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- Multiple sclerosis prevalence in the United States commercially insured population
- (2016) Piyameth Dilokthornsakul et al. NEUROLOGY
- Vaccine hesitancy: Definition, scope and determinants
- (2015) Noni E. MacDonald VACCINE
- Vaccine hesitancy
- (2013) Eve Dubé et al. Human Vaccines & Immunotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search